CU Medical Systems, Inc. (KOSDAQ: 115480)
South Korea
· Delayed Price · Currency is KRW 746.00
-18.00 (-2.36%)
Oct 14, 2024, 3:19 PM KST
CU Medical Systems Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 39,322 | 41,803 | 46,957 | 35,402 | 28,319 | 27,931 | Upgrade
|
| Other Revenue | -0 | -0 | -0 | - | - | -0 | Upgrade
|
| Revenue | 39,322 | 41,803 | 46,957 | 35,402 | 28,319 | 27,931 | Upgrade
|
| Revenue Growth (YoY) | -19.87% | -10.98% | 32.64% | 25.01% | 1.39% | -63.39% | Upgrade
|
| Cost of Revenue | 19,332 | 21,479 | 22,309 | 16,980 | 15,928 | 15,601 | Upgrade
|
| Gross Profit | 19,990 | 20,324 | 24,648 | 18,422 | 12,391 | 12,330 | Upgrade
|
| Selling, General & Admin | 9,472 | 9,186 | 9,312 | 8,072 | 9,895 | 7,786 | Upgrade
|
| Research & Development | 2,615 | 2,912 | 2,623 | 1,845 | 1,355 | 1,288 | Upgrade
|
| Other Operating Expenses | -1.67 | 108.32 | 212.62 | 100.13 | 69.66 | 48.23 | Upgrade
|
| Operating Expenses | 15,057 | 15,264 | 13,366 | 16,047 | 21,261 | 11,400 | Upgrade
|
| Operating Income | 4,933 | 5,060 | 11,282 | 2,376 | -8,870 | 929.75 | Upgrade
|
| Interest Expense | -554.49 | -325.57 | -454.24 | -1,136 | -3,135 | -4,398 | Upgrade
|
| Interest & Investment Income | 194.37 | 89.71 | 98.72 | 162.01 | 206.28 | 238.92 | Upgrade
|
| Earnings From Equity Investments | - | 105.46 | - | 52.92 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -52.44 | -107.07 | 311.12 | 363.39 | -263.33 | 129.76 | Upgrade
|
| Other Non Operating Income (Expenses) | 21.3 | 137.38 | -347.03 | -4,082 | -323.67 | -358.06 | Upgrade
|
| EBT Excluding Unusual Items | 4,542 | 4,960 | 10,891 | -2,264 | -12,386 | -3,457 | Upgrade
|
| Gain (Loss) on Sale of Investments | -6,921 | -9,637 | -1,024 | -8,046 | 636.13 | -813.4 | Upgrade
|
| Gain (Loss) on Sale of Assets | 25 | 14.42 | 861.77 | -63.41 | 412.09 | - | Upgrade
|
| Asset Writedown | -3,784 | -2,781 | -370.57 | -5,267 | -6,869 | - | Upgrade
|
| Other Unusual Items | - | - | 87.97 | 499.72 | -83.06 | -97.37 | Upgrade
|
| Pretax Income | -6,138 | -7,443 | 10,446 | -15,140 | -18,290 | -4,368 | Upgrade
|
| Income Tax Expense | 406.42 | 692.81 | 934.62 | -999.21 | 2,459 | -1,013 | Upgrade
|
| Earnings From Continuing Operations | -6,544 | -8,136 | 9,511 | -14,141 | -20,749 | -3,355 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | -4,832 | 410.91 | Upgrade
|
| Net Income to Company | -6,544 | -8,136 | 9,511 | -14,141 | -25,581 | -2,944 | Upgrade
|
| Minority Interest in Earnings | -43.8 | -67.68 | -85.88 | 160.15 | -158.78 | 33.04 | Upgrade
|
| Net Income | -6,588 | -8,204 | 9,425 | -13,981 | -25,740 | -2,911 | Upgrade
|
| Net Income to Common | -6,588 | -8,204 | 9,425 | -13,981 | -25,740 | -2,911 | Upgrade
|
| Shares Outstanding (Basic) | 48 | 48 | 45 | 34 | 22 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 48 | 48 | 45 | 34 | 22 | 16 | Upgrade
|
| Shares Change (YoY) | 3.80% | 5.90% | 33.07% | 52.90% | 36.70% | 3.71% | Upgrade
|
| EPS (Basic) | -136.89 | -171.59 | 208.78 | -412.11 | -1160.04 | -179.35 | Upgrade
|
| EPS (Diluted) | -136.89 | -172.00 | 208.78 | -412.11 | -1160.04 | -179.35 | Upgrade
|
| Free Cash Flow | -9,713 | 1,893 | -8,465 | -4,696 | 7,133 | -5,944 | Upgrade
|
| Free Cash Flow Per Share | -201.81 | 39.59 | -187.50 | -138.42 | 321.49 | -366.20 | Upgrade
|
| Gross Margin | 50.84% | 48.62% | 52.49% | 52.04% | 43.75% | 44.14% | Upgrade
|
| Operating Margin | 12.55% | 12.11% | 24.03% | 6.71% | -31.32% | 3.33% | Upgrade
|
| Profit Margin | -16.75% | -19.62% | 20.07% | -39.49% | -90.89% | -10.42% | Upgrade
|
| Free Cash Flow Margin | -24.70% | 4.53% | -18.03% | -13.26% | 25.19% | -21.28% | Upgrade
|
| EBITDA | 7,072 | 6,995 | 12,933 | 4,320 | -4,478 | 4,248 | Upgrade
|
| EBITDA Margin | 17.98% | 16.73% | 27.54% | 12.20% | -15.81% | 15.21% | Upgrade
|
| D&A For EBITDA | 2,138 | 1,935 | 1,651 | 1,945 | 4,392 | 3,318 | Upgrade
|
| EBIT | 4,933 | 5,060 | 11,282 | 2,376 | -8,870 | 929.75 | Upgrade
|
| EBIT Margin | 12.55% | 12.11% | 24.03% | 6.71% | -31.32% | 3.33% | Upgrade
|
| Effective Tax Rate | - | - | 8.95% | - | - | - | Upgrade
|
| Advertising Expenses | - | 817.01 | 995.38 | 194.38 | 123.9 | 494.44 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.